Literature DB >> 23044873

Steroidogenic factor-1 and human disease.

Ranna El-Khairi1, John C Achermann.   

Abstract

Steroidogenic factor-1 (SF-1) (Ad4BP, NR5A1) is a nuclear receptor that plays a key role in adrenal and reproductive development and function. Deletion of the gene encoding Sf-1 (Nr5a1) in mice results in severe developmental defects of the adrenal gland and gonad. Consequently, initial work on the potential effects of SF-1 disruption in humans focused on individuals with primary adrenal failure, a 46,XY karyotype, complete gonadal dysgenesis, and Müllerian structures. This is a rare phenotype, but has been reported on two occasions, because of alterations that affect key DNA-binding domains of SF-1. Attention then turned to a potential wider role of SF-1 in human adrenal and reproductive disorders. Although changes in SF-1 only very rarely cause isolated adrenal failure, it is emerging that variations in SF-1 are a surprisingly frequent cause of reproductive dysfunction in humans. In 46,XY disorders of sex development, a spectrum of phenotypes has been reported including severe and partial forms of gonadal (testicular) dysgenesis, hypospadias, anorchia with microphallus, and even male factor infertility. In 46,XX females, alterations in SF-1 are associated with primary ovarian insufficiency. Thus, SF-1 seems be a more significant factor in human reproductive health than was first envisioned, with implications for adults as well as children. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23044873      PMCID: PMC5159746          DOI: 10.1055/s-0032-1324720

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  54 in total

1.  Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function.

Authors:  Lin Lin; Pascal Philibert; Bruno Ferraz-de-Souza; Daniel Kelberman; Tessa Homfray; Assunta Albanese; Veruska Molini; Neil J Sebire; Silvia Einaudi; Gerard S Conway; Ieuan A Hughes; J Larry Jameson; Charles Sultan; Mehul T Dattani; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

Review 2.  Update--steroidogenic factor 1 (SF-1, NR5A1).

Authors:  B Köhler; J C Achermann
Journal:  Minerva Endocrinol       Date:  2010-06       Impact factor: 2.184

3.  Predominant Sertoli cell deficiency in a 46,XY disorders of sex development patient with a new NR5A1/SF-1 mutation transmitted by his unaffected father.

Authors:  Pascal Philibert; Michel Polak; Ana Colmenares; Stephen Lortat-Jacob; Françoise Audran; Francis Poulat; Charles Sultan
Journal:  Fertil Steril       Date:  2010-12-15       Impact factor: 7.329

4.  Pubertal androgenization and gonadal histology in two 46,XY adolescents with NR5A1 mutations and predominantly female phenotype at birth.

Authors:  M Cools; P Hoebeke; K P Wolffenbuttel; H Stoop; R Hersmus; M Barbaro; A Wedell; H Brüggenwirth; L H J Looijenga; S L S Drop
Journal:  Eur J Endocrinol       Date:  2011-11-11       Impact factor: 6.664

5.  Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids.

Authors:  Y Sadovsky; P A Crawford; K G Woodson; J A Polish; M A Clements; L M Tourtellotte; K Simburger; J Milbrandt
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

Review 6.  Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development.

Authors:  L Lin; J C Achermann
Journal:  Sex Dev       Date:  2008-11-05       Impact factor: 1.824

7.  Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function.

Authors:  Michelle L Bland; Robert C Fowkes; Holly A Ingraham
Journal:  Mol Endocrinol       Date:  2004-01-15

8.  A shared promoter element regulates the expression of three steroidogenic enzymes.

Authors:  D A Rice; A R Mouw; A M Bogerd; K L Parker
Journal:  Mol Endocrinol       Date:  1991-10

9.  Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists.

Authors:  Mabrouka Doghman; Julie Cazareth; Dominique Douguet; Franck Madoux; Peter Hodder; Enzo Lalli
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958

10.  Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience.

Authors:  Lin Lin; Wen-Xia Gu; Gokhan Ozisik; Wing S To; Catherine J Owen; J Larry Jameson; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

View more
  20 in total

Review 1.  The orphan nuclear receptors at their 25-year reunion.

Authors:  Shannon E Mullican; Joanna R Dispirito; Mitchell A Lazar
Journal:  J Mol Endocrinol       Date:  2013-11-26       Impact factor: 5.098

2.  Sex redefined.

Authors:  Claire Ainsworth
Journal:  Nature       Date:  2015-02-19       Impact factor: 49.962

Review 3.  Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major of dilemma.

Authors:  A D Fisher; J Ristori; E Fanni; G Castellini; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2016-06-10       Impact factor: 4.256

4.  Exome sequencing for the diagnosis of 46,XY disorders of sex development.

Authors:  Ruth M Baxter; Valerie A Arboleda; Hane Lee; Hayk Barseghyan; Margaret P Adam; Patricia Y Fechner; Renee Bargman; Catherine Keegan; Sharon Travers; Susan Schelley; Louanne Hudgins; Revi P Mathew; Heather J Stalker; Roberto Zori; Ora K Gordon; Leigh Ramos-Platt; Anna Pawlikowska-Haddal; Ascia Eskin; Stanley F Nelson; Emmanuèle Délot; Eric Vilain
Journal:  J Clin Endocrinol Metab       Date:  2014-11-10       Impact factor: 5.958

Review 5.  Genetics of human female infertility†.

Authors:  Svetlana A Yatsenko; Aleksandar Rajkovic
Journal:  Biol Reprod       Date:  2019-09-01       Impact factor: 4.285

6.  Clinicopathological significance of steroidogenic factor-1 expression in ovarian cancer versus ovarian sex cord stromal tumor.

Authors:  Zhuo-ying Hu; Liang-dan Tang; Hong-yu Zhang; Jing-ya Niu; Meng Lou
Journal:  Tumour Biol       Date:  2015-01-22

7.  Steroidogenic factor 1 differentially regulates fetal and adult leydig cell development in male mice.

Authors:  Tatiana Karpova; Kumarasamy Ravichandiran; Lovella Insisienmay; Daren Rice; Valentine Agbor; Leslie L Heckert
Journal:  Biol Reprod       Date:  2015-08-12       Impact factor: 4.285

8.  A rare de novo interstitial duplication of 15q15.3q21.2 in a boy with severe short stature, hypogonadism, global developmental delay and intellectual disability.

Authors:  Haiming Yuan; Zhe Meng; Lina Zhang; Xiangyang Luo; Liping Liu; Mengfan Chen; Xinwei Li; Weiwei Zhao; Liyang Liang
Journal:  Mol Cytogenet       Date:  2016-01-11       Impact factor: 2.009

9.  Gonadotroph tumours with a low SF-1 labelling index are more likely to recur and are associated with enrichment of the PI3K-AKT pathway.

Authors:  Richard A Hickman; Jeffrey N Bruce; Marc Otten; Alexander G Khandji; Xena E Flowers; Markus Siegelin; Beatriz Lopes; Phyllis L Faust; Pamela U Freda
Journal:  Neuropathol Appl Neurobiol       Date:  2020-12-20       Impact factor: 8.090

10.  Whole-Exome Sequencing in the Differential Diagnosis of Primary Adrenal Insufficiency in Children.

Authors:  Li F Chan; Daniel C Campbell; Tatiana V Novoselova; Adrian J L Clark; Louise A Metherell
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-05       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.